CLR/RAMP1, or CGRP receptor, antagonists have been developed for thetreatment of migraine headache and osteoarthritis pain; whereas CLR/RAMP2, orADM receptor, antagonists are being developed for the treatment of tumorgrowth/metastasis. Here, RAMP2 is linked to Headache.